Wendy Cameron
Director/Board Member at Beijing Tong Ren Tang Ming Qi Group LLC
Wendy Cameron active positions
Companies | Position | Start | End |
---|---|---|---|
Beijing Tong Ren Tang Ming Qi Group LLC | Director/Board Member | 2002-12-31 | - |
Corporate Officer/Principal | 2009-10-22 | - |
Career history of Wendy Cameron
Former positions of Wendy Cameron
Companies | Position | Start | End |
---|---|---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Director/Board Member | 2001-12-31 | 2018-06-28 |
Independent Dir/Board Member | 2001-12-31 | 2018-06-28 | |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Director/Board Member | 2001-12-31 | 2007-10-01 |
Cameron Coca Cola Bottling Co.
Cameron Coca Cola Bottling Co. Beverages: Non-AlcoholicConsumer Non-Durables Part of The Coca-Cola Co., Cameron Coca Cola Bottling Co. bottles Coca-Cola soft drink products. Cameron Coca Cola Bottling was acquired by Coca-Cola Enterprises, Inc. /Old/ on October 21, 1998. | General Counsel | 1980-12-31 | 1997-12-31 |
Sales & Marketing | 1980-12-31 | 1997-12-31 | |
Washington Hospital Healthcare System
Washington Hospital Healthcare System Hospital/Nursing ManagementHealth Services The American company was founded in 1985. The CEO is Kimberly Hartz. | Chairman | 2011-07-13 | - |
Washington Health System Foundation | Director/Board Member | 2010-05-12 | - |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Director/Board Member | 2001-12-31 | - |
Independent Dir/Board Member | 2011-07-12 | - |
Training of Wendy Cameron
Otterbein College | Undergraduate Degree |
Statistics
International
United States | 8 |
United Kingdom | 2 |
Operational
Director/Board Member | 5 |
Independent Dir/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 4 |
Consumer Non-Durables | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 7 |
---|---|
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Health Technology |
Beijing Tong Ren Tang Ming Qi Group LLC | |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
Cameron Coca Cola Bottling Co.
Cameron Coca Cola Bottling Co. Beverages: Non-AlcoholicConsumer Non-Durables Part of The Coca-Cola Co., Cameron Coca Cola Bottling Co. bottles Coca-Cola soft drink products. Cameron Coca Cola Bottling was acquired by Coca-Cola Enterprises, Inc. /Old/ on October 21, 1998. | Consumer Non-Durables |
Washington Health System Foundation | Miscellaneous |
Washington Hospital Healthcare System
Washington Hospital Healthcare System Hospital/Nursing ManagementHealth Services The American company was founded in 1985. The CEO is Kimberly Hartz. | Health Services |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Wendy Cameron
- Experience